-Bridge the Gap Bring the Change

Tag Roche

Press Release- Roche relinquishes Trastuzumab patent in India #Goodnews

16 August 2013 Swiss pharma major Roche has just announced that it is relinquishing the patent for its breast-cancer drug Trastuzumab in India. The announcement comes in the face of mounting challenges to Roche’s monopoly on this life-saving drug from civil society activists… Continue Reading →

Ever wondered why Novartis and Roche do not compete ? #Pharma

    Expectations of structural change and divestments will be reignited by the Symonds announcement, note analysts at Deutsche Bank. One particular conundrum for investors is the 33 percent shareholding that Novartis holds in its compatriot Roche. Jimenez has ascribed an… Continue Reading →

PRESS RELEASE- Demand for compulsory licensing for Trastuzumab, a life-saving drug for women with HER2+ breast cancer #womensday

CAMPAIGN FOR AFFORDABLE TRASTUZUMAB 8 March 2013   The Campaign for Affordable Trastuzumab has called on the Commerce Minister to mark International Women’s Day 2013 with an announcement of compulsory licensing for Trastuzumab, a life-saving drug for women with HER2+… Continue Reading →

India’s cancer burden: Why the govt’s CL ruling is so important #drugpricing #goodnews

Jan 15, 2013, First post Early last year, when the Union government allowed the production of Nexavar, a liver and kidney cancer drug, by an Indian company against the wishes of multinational pharma major Bayer, the prices of several indigenously… Continue Reading →

Immediate Release- Patients succeed in overturning first ever product patent on medicine in India #goodnews

Hope for hep-C patients: Context and Background  Today, the Bench of Intellectual Property Appellate Board, comprising Justice Prabha Sridevan (Chairperson) and Mr DPS Parmar (Technical Member), set aside the first ever product patent on a medicine granted in India to… Continue Reading →

© 2023 Kractivism — Powered by WordPress

Theme by Anders NorenUp ↑